ArticleBMC psychiatry2026
Predicting the final response and remission of electroconvulsive therapy in treating major depressive disorder: exploring the earliest predictive factors for early improvement.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The postictal systems window hypothesis of electroconvulsive therapy in major depression.Frontiers in psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundTo date, no study has investigated the earliest predictors of early improvement during electroconvulsive therapy (ECT) in patients with major depressive disorder (MDD). The primary objective of this study was to compare the predictive ability of the improvement rate in the 17-item Hamilton Depression Rating Scale (HAMD-17) scores after each ECT session for final treatment response and remission, thereby identifying the earliest early improvement predictors for ECT efficacy in MDD.
methodsHAMD-17 scores were collected from 143 patients with MDD after each ECT session. Treatment response was defined as a ≥ 50% reduction in HAMD-17 scores from baseline, and remission was defined as a HAMD-17 score ≤ 7. Predictive factors identified as significant in univariate analyses (p < 0.05) were further evaluated using receiver operating characteristic (ROC) curve analysis. An area under the ROC curve (AUC) value > 0.8 was considered to indicate good discriminative ability. The earliest time point at which the AUC first exceeded 0.8 was determined as the earliest early improvement predictor for treatment outcomes. The optimal threshold of early improvement for predicting response and remission was determined using the Youden index.
resultsOf the 143 patients who received ECT, 76.92% achieved treatment response and 58.04% achieved remission. An improvement rate of ≥ 42.21% in HAMD-17 scores after three ECT sessions optimally predicted final response, while an improvement rate of ≥ 47.05% after four sessions optimally predicted final remission.
conclusionEarly improvement during the course of ECT has predictive value for treatment outcomes. Close monitoring of treatment efficacy in the early stages of ECT may facilitate timely adjustment of treatment strategies and improve overall outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.